United States · FDA National Drug Code directory
Fenofibrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-3121_81d94e71-5260-d81d-f3b9-070ec3c0743a
- Product NDC
- 60505-3121
- Form
- CAPSULE
- Composition / generic term
- Fenofibrate
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130726
- Source listing expiry
- 20261231
Source-listed ingredients
- FENOFIBRATE — 130 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (60505-3121-1) · 60505-3121-1
- 30 CAPSULE in 1 BOTTLE (60505-3121-3) · 60505-3121-3
- 500 CAPSULE in 1 BOTTLE (60505-3121-5) · 60505-3121-5
- 90 CAPSULE in 1 BOTTLE (60505-3121-9) · 60505-3121-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →